Market Overview

Credit Suisse Downgrades Vital Therapies to Neutral, Maintains $16.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for VTL

DateFirmActionFromTo
Aug 2015Credit SuisseDowngradesOutperformNeutral
Aug 2015William BlairDowngradesOutperformMarket Perform
Aug 2015SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for VTL
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (VTL)